Skip to content
TrustList
Cota Capital logo
Investor

Cota Capital

Multi-stage technology investor backing enterprise startups building new categories

Cota Capital cover

About Cota Capital

Cota Capital is an investment firm that works with founders creating what it calls net new technologies. It has spent over a decade helping founders in the enterprise. Its thesis is that enterprise technology will keep reshaping industries.

What Cota Capital offers

  • Multi-stage investing — engages with companies at several stages of growth.
  • Knowledge support — combines funding with operating expertise, industry insight, competitive intelligence and a wide network.
  • Cota Connect — an event gathering founders, investors and industry leaders.

Who it works with

Cota's listed portfolio spans point-of-care ultrasound, energy storage, streaming, physical security, restaurant commerce, wealth management, billing software, cloud infrastructure and satellite imaging.

Key facts

  • Focus: enterprise technology
  • Approach: true partnership with founders

Profile written by TrustList from the business's own published information, Oct 2026.

Categories & features

Rankings

As of 2026-10-05. Organic ranks only; sponsored placements are never ranks.

Ask TrustList to introduce you to Cota Capital

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Cota Capital

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Cota Capital.

Cota Capital alternatives

Similar listings buyers compare against this one.

Higher education growth partner offering enrolment marketing, recruitment, retention and institutional strategy to universities

Hybrid investment and advisory firm backing fintech startups facing financial and regulatory change

Early-stage venture capital firm partnering with founders across the United States

Stem cell and drug discovery research company supplying iPSC tools, human tissue testing and clinical services

Early-stage venture capital firm backing software-as-a-service and marketplace startups